Roxburgh Park mum Souad Yassir battles rare cancer which costs $5469 a ... Herald Sun A Federal Department of Health spokeswoman said it was up to the pharmaceutical company that manufactured Afinitor, or everolimus, to apply to the Therapeutic Goods Administration so the treatment could be funded for Ms Yassir's condition under the PBS. |
